Aqemia

We are very proud to announce our $30M Series A with @eurazeo @Bpifrance and @Elaia_Partners 🚀 to leverage our unique Deep Physics-powered AI to uncover drug candidates at scale!
We have many open positions in our amazing team 👉 aqemia.com/careers.

businesswire.com/news/home/2022…

The @Polytechnique alumni association organized a meetup on AI for graph-structured data at @dataiku
Aqemia CTO @MagaliBeffy and ML Lead @j_boitreaud were among the speakers.
They presented how we leverage GNN to speed-up #drugdiscovery and learn from physics-based simulations

Aqemia is one of "the 21 most promising healthtech startups of 2022, according to top VCs" in @BusinessInsider

Thank you James Buxton M.D. from @NEA for talking about our work and how we are "beating other competitors in speed and accuracy"!

businessinsider.com/21-most-promis…

We are very pleased to welcome you tonight for our 1st event at @PariSanteCampus 🚀🚀
#drugdiscovery #MachineLearning #SoftwareEngineering

Come and join us next week to discover how the synergy created between our teams, from chemistry to machine learning, disrupts drug discovery!
See you on June 23rd at 7:30pm, Paris XV
=> Registration: docs.google.com/forms/d/e/1FAI…